Thus, IL-6 produced in the upper respiratory tract seems to be mainly responsible for the induction of systemic symptoms in infected humans, while IL-6 is not directly involved in progression to pneumonia development. This evidence concerns the gene IL6 and susceptibility to pneumonia measurement.